Product References
GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia.
Molecular cancer research : MCR
Sun W,Guo J,McClellan D,Poeschla A,Bareyan D,Casey MJ,Cairns BR,Tantin D,Engel ME
PA5-23728 was used in Immunoprecipitation to identify a noncanonical transcriptional control mechanism in T-ALL which supports GFI1-mediated transactivation in partnership with IKAROS and suggest competition between LSD1-containing repressive complexes and others favoring transactivation.
Fri Apr 01 00:00:00 UTC 2022
GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia.
Molecular cancer research : MCR
Sun W,Guo J,McClellan D,Poeschla A,Bareyan D,Casey MJ,Cairns BR,Tantin D,Engel ME
PA5-23728 was used in Immunoprecipitation to identify a noncanonical transcriptional control mechanism in T-ALL which supports GFI1-mediated transactivation in partnership with IKAROS and suggest competition between LSD1-containing repressive complexes and others favoring transactivation.
Fri Apr 01 00:00:00 UTC 2022
Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities.
Haematologica
Scott C,Downes DJ,Brown JM,Beagrie R,Olijnik AA,Gosden M,Schwessinger R,Fisher CA,Rose A,Ferguson DJP,Johnson E,Hill QA,Okoli S,Renella R,Ryan K,Brand M,Hughes J,Roy NBA,Higgs DR,Babbs C,Buckle VJ
PA5-23728 was used in Flow Cytometry to provide important pointers to the pathways affected in CDA-I which for the first time can now be pursued in the tractable culture system utilised here.
Mon Nov 01 00:00:00 UTC 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models.
Molecular cancer therapeutics
Sun D,Nikonova AS,Zhang P,Deneka AY,Fitzgerald ME,Michael RE,Lee L,Lilly AC,Fisher SL,Phillips AJ,Nasveschuk CG,Proia DA,Tu Z,Golemis EA
PA5-23728 was used in Western Blot to suggest that BRD-mediated transcriptional suppression merits further exploration in the setting of SCLC.
Sun Aug 01 00:00:00 UTC 2021
Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models.
Molecular cancer therapeutics
Sun D,Nikonova AS,Zhang P,Deneka AY,Fitzgerald ME,Michael RE,Lee L,Lilly AC,Fisher SL,Phillips AJ,Nasveschuk CG,Proia DA,Tu Z,Golemis EA
PA5-23728 was used in Western Blot to suggest that BRD-mediated transcriptional suppression merits further exploration in the setting of SCLC.
Sun Aug 01 00:00:00 UTC 2021